MX2017009408A - Compuestos antihelminticos, composiciones y metodo para usar los mismos. - Google Patents

Compuestos antihelminticos, composiciones y metodo para usar los mismos.

Info

Publication number
MX2017009408A
MX2017009408A MX2017009408A MX2017009408A MX2017009408A MX 2017009408 A MX2017009408 A MX 2017009408A MX 2017009408 A MX2017009408 A MX 2017009408A MX 2017009408 A MX2017009408 A MX 2017009408A MX 2017009408 A MX2017009408 A MX 2017009408A
Authority
MX
Mexico
Prior art keywords
compounds
compositions
ring
anthelmintic compounds
alkoxyalkyl
Prior art date
Application number
MX2017009408A
Other languages
English (en)
Inventor
Long Alan
Edward Wilkinson Douglas
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Publication of MX2017009408A publication Critical patent/MX2017009408A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Abstract

La presente invención se relaciona a compuestos antihelmínticos novedosos de la fórmula (IA) enseguida: en donde, Y se selecciona del grupo que consiste de -H, arilo, cicloalquilo, cicloalquenilo, heteroarilo, heterociclilo, alquilo, haloalquilo y alcoxialquilo; y Z se selecciona del grupo que consiste de arilo, cicloalquilo, cicloalquenilo, heteroarilo, heterociclilo, alquilo, haloalquilo y alcoxialquilo. Las variables Anillo A, Anillo B, Anillo C, X1, X6 y X8 son como se definen en la presente. La invención también se relaciona a composiciones parasiticidas que comprenden los compuestos, y métodos y usos de los compuestos para tratar y prevenir infecciones e infestaciones parasíticas en animales.
MX2017009408A 2015-01-20 2016-01-20 Compuestos antihelminticos, composiciones y metodo para usar los mismos. MX2017009408A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562105463P 2015-01-20 2015-01-20
PCT/US2016/014148 WO2016118638A1 (en) 2015-01-20 2016-01-20 Anthelmintic compounds, compositions and method of using thereof

Publications (1)

Publication Number Publication Date
MX2017009408A true MX2017009408A (es) 2017-10-02

Family

ID=55299781

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017009408A MX2017009408A (es) 2015-01-20 2016-01-20 Compuestos antihelminticos, composiciones y metodo para usar los mismos.

Country Status (11)

Country Link
US (1) US10597364B2 (es)
EP (1) EP3247701B1 (es)
JP (1) JP6771469B2 (es)
CN (1) CN107257793A (es)
AU (3) AU2016209321B2 (es)
BR (1) BR112017015273A2 (es)
CA (1) CA2973873A1 (es)
ES (1) ES2907461T3 (es)
MX (1) MX2017009408A (es)
NZ (1) NZ734082A (es)
WO (1) WO2016118638A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2545964A1 (en) 2011-07-13 2013-01-16 Phenex Pharmaceuticals AG Novel FXR (NR1H4) binding and activity modulating compounds
BR112018075734A2 (pt) 2016-06-13 2019-04-02 Gilead Sciences, Inc. composto, composição farmacêutica, método para tratar um paciente com uma doença ou condição mediada pelo menos em parte por fxr, e, uso de um composto.
CA2968836A1 (en) 2016-06-13 2017-12-13 Gilead Sciences, Inc. Fxr (nr1h4) modulating compounds
EA037520B1 (ru) 2016-07-20 2021-04-07 Новартис Аг Производные аминопиридина и их применение в качестве селективных ингибиторов alk–2
PL3600309T3 (pl) 2017-03-28 2022-11-07 Gilead Sciences, Inc. Skojarzenia terapeutyczne do leczenia chorób wątroby
BR122020005073A2 (pt) 2017-08-04 2020-10-13 Skyhawk Therapeutics, Inc. Composto, composição farmacêutica e uso do composto
TWI793151B (zh) 2017-08-23 2023-02-21 瑞士商諾華公司 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途
AR116109A1 (es) 2018-07-10 2021-03-31 Novartis Ag Derivados de 3-(5-amino-1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos
AU2019301944B2 (en) 2018-07-10 2022-02-24 Novartis Ag 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and their use in the treatment of IKAROS Family Zinc Finger 2 (IKZF2)-dependent diseases
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
JP7265635B2 (ja) 2019-01-15 2023-04-26 ギリアード サイエンシーズ， インコーポレイテッド Ｆｘｒ（ｎｒ１ｈ４）調節化合物
MA54758A (fr) 2019-01-18 2022-04-27 Astrazeneca Ab Inhibiteurs de pcsk9 et leurs procédés d'utilisation
JP2022521467A (ja) 2019-02-05 2022-04-08 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
KR20210129128A (ko) 2019-02-19 2021-10-27 길리애드 사이언시즈, 인코포레이티드 Fxr 효능제의 고체 형태
US11560388B2 (en) * 2019-03-19 2023-01-24 Boehringer Ingelheim Vetmedica Gmbh Anthelmintic aza-benzothiophene and aza-benzofuran compounds
AR119731A1 (es) 2019-05-17 2022-01-05 Novartis Ag Inhibidores del inflamasoma nlrp3
US11129829B2 (en) 2019-06-17 2021-09-28 Skyhawk Therapeutics, Inc. Methods for modulating splicing
BR112022007627A2 (pt) 2019-10-25 2022-07-12 Gilead Sciences Inc Compostos moduladores do glp-1r
EP4061367A1 (en) 2019-11-22 2022-09-28 Incyte Corporation Combination therapy comprising an alk2 inhibitor and a jak2 inhibitor
MX2022014356A (es) 2020-05-15 2023-03-09 Algen Biotechnologies Inc Ciertas composiciones quimicas y metodos de uso de las mismas.
WO2021257532A1 (en) 2020-06-16 2021-12-23 Incyte Corporation Alk2 inhibitors for the treatment of anemia
WO2022109182A1 (en) 2020-11-20 2022-05-27 Gilead Sciences, Inc. Polyheterocyclic glp-1 r modulating compounds
US11932630B2 (en) 2021-04-16 2024-03-19 Novartis Ag Heteroaryl aminopropanol derivatives
JP2024514009A (ja) 2021-04-21 2024-03-27 ギリアード サイエンシーズ， インコーポレイテッド カルボキシ－ベンズイミダゾールｇｌｐ－１ｒ調節化合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4208254A1 (de) 1992-03-14 1993-09-16 Hoechst Ag Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid
AU1631699A (en) 1997-12-18 1999-07-05 E.I. Du Pont De Nemours And Company Cyclohexylamine arthropodicides and fungicides
AU2001233044A1 (en) 2000-01-28 2001-08-07 Akkadix Corporation Methods for killing nematodes and nematode eggs using bis-amino-1,2,4-thiadiazoles
US7199147B2 (en) 2001-06-12 2007-04-03 Dainippon Sumitomo Pharma Co., Ltd. Rho kinase inhibitors
EP1689722A2 (en) * 2003-10-10 2006-08-16 Bayer Pharmaceuticals Corporation 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders
US7880000B2 (en) * 2004-05-07 2011-02-01 Amgen Inc. Protein kinase modulators and method of use
DE102005032838A1 (de) * 2005-07-14 2007-02-08 Merck Patent Gmbh Mischung von Onium-Alkylsulfonaten und Onium-Alkylsulfiten
JPWO2007063839A1 (ja) * 2005-11-30 2009-05-07 塩野義製薬株式会社 シクロヘキサン誘導体
TW200938203A (en) 2007-12-17 2009-09-16 Intervet Int Bv Anthelmintic agents and their use
TW201041868A (en) 2009-03-20 2010-12-01 Intervet Int Bv Anthelmintic agents and their use
TW201111358A (en) 2009-06-18 2011-04-01 Intervet Int Bv Anthelmintic agents and their use
IN2012DN02471A (es) * 2009-10-09 2015-08-21 Irm Llc
EP2569302A1 (en) * 2010-05-13 2013-03-20 Amgen, Inc Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
US8952037B2 (en) * 2010-05-13 2015-02-10 Amgen Inc. Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
EP2468096A1 (en) 2010-12-21 2012-06-27 Intervet International BV Anthelmintic combinations
US8530461B2 (en) * 2011-12-29 2013-09-10 Boehringer Ingelheim International Gmbh Azetidine derivatives
EP2882733B1 (en) * 2012-08-08 2017-04-26 Novartis Tiergesundheit AG Substituted azines as pesticides
ES2893777T3 (es) * 2012-11-20 2022-02-10 Boehringer Ingelheim Animal Health Usa Inc Compuestos y composiciones antihelmínticas y procedimiento de utilización de los mismos
HRP20211855T1 (hr) * 2013-03-12 2022-03-04 Vertex Pharmaceuticals Incorporated Inhibitori dnk-pk
JP6140373B2 (ja) 2013-11-18 2017-05-31 ノバルティス ティーアゲズントハイト アーゲー 新規化合物
AU2015264336B2 (en) 2014-05-19 2018-08-30 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic compounds

Also Published As

Publication number Publication date
AU2020204400A1 (en) 2020-07-30
ES2907461T3 (es) 2022-04-25
US10597364B2 (en) 2020-03-24
JP2018502877A (ja) 2018-02-01
US20180009754A1 (en) 2018-01-11
EP3247701B1 (en) 2021-09-22
CA2973873A1 (en) 2016-07-28
EP3247701A1 (en) 2017-11-29
NZ734082A (en) 2019-01-25
JP6771469B2 (ja) 2020-10-21
AU2016209321A1 (en) 2017-08-17
CN107257793A (zh) 2017-10-17
BR112017015273A2 (pt) 2018-01-09
AU2019202773A1 (en) 2019-05-16
WO2016118638A1 (en) 2016-07-28
AU2016209321B2 (en) 2019-05-09
AU2019202773B2 (en) 2020-07-02

Similar Documents

Publication Publication Date Title
NZ734082A (en) Anthelmintic compounds, compositions and method of using thereof
MX2019003112A (es) Compuestos antihelminticos y composiciones y metodo de uso de los mismos.
MX2018004347A (es) Compuestos utiles como inmunomoduladores.
PH12017500408A1 (en) Heteroaryl compunds as btk inhibitors and uses thereof
MX2017016363A (es) Fenoxifenilamidinas sustituidas con halogeno y el uso de estas como fungicidas.
NZ726874A (en) Anthelmintic compounds
MX2018000050A (es) Fenoxihalogenofenilamidinas y su uso como fungicidas.
MX2016005693A (es) Compuestos de isoxazolina antiparasitarios y pesticidas.
PH12016501963A1 (en) Macrocyclic pyrimidine derivatives
GEP20227353B (en) Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
MX2017008431A (es) Compuestos ciclicos sustituidos con un sistema de anillos condensado.
PH12016501999A1 (en) Novel bacteriophage and composition containing same
MX2018016339A (es) Compuestos heterociclicos antiinfecciosos y sus usos.
NZ765435A (en) Polymorphs
MX2017008074A (es) DERIVADOS DE IMIDAZOPIRIDAZINA COMO INHIBIDORES DE FOSFOINOSITIDA-3-QUINASAS BETA (PI3Kß).
GEP20186922B (en) Aminoester derivatives
SG10201901578UA (en) Processes for the preparation of pyrimidinylcyclopentane compounds
MX2017008076A (es) DERIVADOS DE IMIDAZOPIRIDAZINA ENLAZADOS A HETEROCICLILO COMO INHIBIDORES DE PI3Kß.
MX2019004266A (es) Compuestos de vinil isoxazolina pesticidas y parasiticidas.
PH12015502060A1 (en) Hydrochloride salts of an antibiotic compound
MX2016009250A (es) Nuevos imidazoles para el tratamiento y profilaxis de la infeccion por virus sincicial respiratorio.
TH160100B (th) สารประกอบชนิดใหม่และองค์ประกอบทางเภสัชกรรมของมันสำหรับการรักษา ซิสติกไฟโบรซิส
PH22015000376U1 (en) An ointment for treating skin infection caused by staphylococcus aureus bacteria
PH22015000375U1 (en) Process of producing an ointment for treating skin infection caused by staphylococcus aureus bacteria